Cargando…
Long-term outcomes with agalsidase alfa enzyme replacement therapy: Analysis using deconstructed composite events
This is a retrospective analysis of Fabry Outcome Survey data from children/adults (n = 677) receiving agalsidase alfa enzyme replacement therapy for a median of 3 years, examining cerebrovascular, cardiac, and renal morbidity endpoints separately. Cardiac events occurred at younger ages than cerebr...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5684503/ https://www.ncbi.nlm.nih.gov/pubmed/29159077 http://dx.doi.org/10.1016/j.ymgmr.2017.10.008 |